Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SER120 Nasal Spray for Nocturia
NCT00937378Phase 3Completed
- Sponsor
- Serenity Pharmaceuticals
- Start
- Jun 2009
- Primary completion
- Aug 2010
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of desmopressin in nocturia, sponsored by Serenity Pharmaceuticals. Started Jun 2009; status: completed.
02
Drugs
desmopressin
03
Conditions
nocturia
Beyond the preview
Go deeper on NCT00937378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00937378.